TG Therapeutics Inc (TGTX): Next-Year EPS Estimate 83.51%
As of 2026-06-04, TG Therapeutics Inc (TGTX) has a next-year EPS growth estimate of 83.51%.
On 2026-06-03, analyst consensus for TGTX's next-year EPS growth shifted from 98.35% to 83.51% — a negative change of 14.84 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -50.18%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 83.51%
- EPS growth this year
- -50.18%
- EPS next quarter (est)
- $0.36
- Last price
- $40.56
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 83.51% | -50.18% | $0.36 | $40.56 |
| 2026-06-03 | 83.51% | -50.18% | $0.36 | $40.11 |
| 2026-06-02 | 98.35% | -53.61% | $0.33 | $36.64 |
| 2026-06-01 | 98.35% | -53.61% | $0.33 | $37.41 |
| 2026-05-31 | 98.35% | -53.61% | $0.33 | $37.94 |
| 2026-05-28 | 98.35% | -53.61% | $0.33 | $38.82 |
| 2026-05-27 | 98.35% | -53.61% | $0.33 | $39.20 |
| 2026-05-26 | 98.35% | -53.61% | $0.33 | $39.73 |
| 2026-05-25 | 98.35% | -53.61% | $0.33 | $38.87 |
| 2026-05-24 | 98.35% | -53.61% | $0.33 | $38.87 |
| 2026-05-21 | 98.35% | -53.61% | $0.33 | $39.24 |
| 2026-05-20 | 98.35% | -53.61% | $0.33 | $39.76 |
| 2026-05-19 | 98.35% | -53.61% | $0.33 | $39.43 |
| 2026-05-18 | 98.35% | -53.61% | $0.33 | $39.48 |
| 2026-05-17 | 98.35% | -53.61% | $0.33 | $39.50 |
| 2026-05-14 | 98.35% | -53.61% | $0.33 | $40.79 |
| 2026-05-13 | 97.89% | -52.93% | $0.34 | $42.88 |
| 2026-05-12 | 97.89% | -52.93% | $0.34 | $42.54 |
| 2026-05-11 | 97.89% | -52.93% | $0.34 | $43.14 |
| 2026-05-10 | 97.89% | -52.93% | $0.34 | $42.86 |
| 2026-05-07 | 97.89% | -52.93% | $0.34 | $43.03 |
| 2026-05-06 | 75.59% | -52.30% | $0.34 | $41.97 |
| 2026-05-05 | 68.20% | -51.84% | $0.28 | $36.10 |
| 2026-05-04 | 68.20% | -51.84% | $0.28 | $35.71 |
| 2026-05-03 | 68.20% | -51.84% | $0.28 | $33.85 |
| 2026-04-30 | 68.20% | -51.84% | $0.28 | $33.78 |
| 2026-04-29 | 68.20% | -51.84% | $0.28 | $33.58 |
| 2026-04-28 | 69.46% | -53.10% | $0.27 | $34.58 |
| 2026-04-27 | 69.46% | -53.10% | $0.27 | $35.38 |
| 2026-04-26 | 69.46% | -53.10% | $0.27 | $36.62 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is TG Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, TG Therapeutics Inc (TGTX) has a next-year EPS growth estimate of 83.51%, based on analyst consensus.
When was the latest EPS estimate revision for TGTX?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 98.35% to 83.51%.
What sector and industry does TG Therapeutics Inc belong to?▾
TG Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TGTX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. TG Therapeutics Inc (TGTX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports